Oct 09, 2024 / 02:30PM GMT
Operator
Good afternoon, ladies and gentlemen. Welcome to the Celadon Pharmaceuticals PLC interim results investor presentation. (Operator Instructions)
And before we begin, as usual, we would just like to submit the following poll. And if you could give that your kind attention, I'm sure the company would be most grateful.
And I would now like to hand you over to CEO, James Short. James, good afternoon, sir.
James Short - Celadon Pharmaceuticals PLC - Chief Executive Officer and Co-Founder
Good afternoon, and thank you everybody, for joining today. I'm also joined by -- first, sorry, for those of you who don't know me, I'm James Short, the CEO and Co-Founder of Celadon Pharmaceutical. I'm also joined by Jonathan Turner, our CFO.
So for those that don't know the company, I'd like to just reiterate that Celadon, when I founded the company, was set up on the basis that we are to produce a pharmaceutical-grade product that will help the quality of life for patients that aren't currently getting it from their current medication. Over the past
Half Year 2024 Celadon Pharmaceuticals PLC Earnings Call Transcript
Oct 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers